The upcoming facility marks a strategic milestone in SOUKYA’s mission to make evidence-based holistic healthcare
Acquisition expands Novo Nordisk’s leadership in obesity-related comorbidities and metabolic diseases
These products strengthen poultry immunity, improve productivity, and support sustainable farming practices~
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators
Experts urge early detection & better access to care
Subscribe To Our Newsletter & Stay Updated